Overview

Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals

Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
Preliminary research has shown that venlafaxine, a medication currently used for treating depression, may also discourage cocaine use in depressed individuals. This study will evaluate the effectiveness of venlafaxine in reducing cocaine use and alleviating depression in individuals addicted to cocaine.
Phase:
Phase 2
Details
Lead Sponsor:
New York State Psychiatric Institute
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Cocaine
Venlafaxine Hydrochloride